TP-3654 (PIM kinase inhibitor)
Current understanding
To be populated as evidence accumulates.
Evidence log
Open questions
Related
Contributing findings
Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.
30-jul-2026
novelty 2
per-area 2
mentions